CDSCO Panel Approves AstraZeneca's Protocol Amendment for Anti-cancer Drug AZD0901 study Dr. Divya Colin4 May 2025 5:45 PM ISTNew Delhi: The Subject Expert Committee (SEC), functional under the Central Drug Standard Control Organisation (CDSCO), has approved AstraZeneca...
Biocon Biologics gets USFDA nod for cancer drug Jobevne Ruchika Sharma10 April 2025 12:39 PM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced that the U.S. Food and Drug Administration (U.S. FDA) has...
Shilpa Biologicals, mAbTree Biologics ink pact for cancer drug Ruchika Sharma18 March 2025 12:30 PM ISTKarnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive partnership...
Merck injected version of Keytruda faces possible patent challenge: Report Ruchika Sharma6 March 2025 5:06 PM ISTMerck's newly developed injected version of its blockbuster cancer drug, Keytruda, may be at the center of a potential patent dispute,...
US Market Pressure Weighs on Glenmark's Q3 Earnings, Profit Below Estimates Farhat Nasim15 Feb 2025 3:35 PM ISTGlenmark reported a consolidated net profit of 3.48 billion rupees (USD 40.15 million) for the quarter ended December 31.
Exempt cancer, rare-disease drugs from tax in budget: Biocon Chief urges govt Ruchika Sharma20 Jan 2025 1:06 PM ISTKiran Mazumdar-Shaw, Chairperson of Biocon, has urged the government to remove tax on medicines used to treat cancer, chronic illnesses, and rare...
Drug Raid Uncovers Rs 6.60 Crore Worth of Spurious Medicines in Kolkata Dr. Bhumika Maikhuri2 Jan 2025 5:45 PM ISTIn a joint investigation conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West...
Health Bulletin 02/ January/ 2025 Dr. Bhumika Maikhuri2 Jan 2025 5:31 PM ISTHere are the top health news for the day:Drug Raid Uncovers Rs 6.60 Crore Worth of Spurious Medicines in KolkataIn a joint investigation conducted by...
Spurious medicines worth Rs 6.60 crore seized in raid at Kolkata premises Ruchika Sharma1 Jan 2025 4:57 PM ISTIn a joint investigation conducted by the Central Drugs Standard Control Organization (CDSCO), East Zone, and the Drugs Control Directorate, West...
Intas Pharma gest CDSCO panel nod to manufacture, market anticancer drug Enzalutamide tablet Susmita Roy27 Nov 2024 5:30 PM ISTNew Delhi: Intas Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization...
Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs Farhat Nasim9 Nov 2024 5:40 PM ISTNew Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...
Reduce price of 3 anti-cancer drugs: Govt asks manufacturers Ruchika Sharma29 Oct 2024 5:46 PM ISTNew Delhi: To ensure the affordable availability of drugs, the government has asked the companies to reduce the prices of three anti-cancer drugs,...
